Pharmacotherapy of adolescent attention deficit hyperactivity disorder: challenges, choices and caveats
about
sameAs
European consensus statement on diagnosis and treatment of adult ADHD: The European Network Adult ADHDAtomoxetine in patients with ADHD: A clinical and pharmacological review of the onset, trajectory, duration of response and implications for patientsSafety of stimulant treatment in attention deficit hyperactivity disorder: part II.Treating attention-deficit/hyperactivity disorder beyond symptom control alone in children and adolescents: a review of the potential benefits of long-acting stimulantsOpen-label dose optimization of methylphenidate modified release long acting (MPH-LA): a post hoc analysis of real-life titration from a 40-week randomized trial.Clinical suggestions for management of stimulant treatment in adolescents.Persistent behavioral impairment caused by embryonic methylphenidate exposure in zebrafishThe therapeutic potential of nicotine and nicotinic agonists for weight control.Emerging drugs for attention-deficit/hyperactivity disorder.Treatment patterns, adherence, and persistence in ADHD: a Canadian perspective.Pharmacotherapy of conduct disorder: Challenges, options and future directions.Repeated exposure of adolescent rats to oral methylphenidate does not induce behavioral sensitization or cross-sensitization to nicotine.Effect of repeated methylphenidate administration on presynaptic dopamine and behaviour in young adult rats.Rates of adherence to pharmacological treatment among children and adolescents with attention deficit hyperactivity disorder.Methylphenidate induces lipid and protein damage in prefrontal cortex, but not in cerebellum, striatum and hippocampus of juvenile rats.Effects of transcutaneous electrical nerve stimulation (TENS) on cognition, behavior, and the rest-activity rhythm in children with attention deficit hyperactivity disorder, combined type.
P2860
Q21260332-0880E622-3E2B-4C11-AB73-E054F68E1B3CQ28267079-D6A7BEC8-AFD3-43E0-9EE0-C43F6CF4ADE6Q30451303-23806985-14DE-4CCD-BD36-ADD72B8459F5Q33746664-BD36B4D0-8BD8-41A2-8608-CA3C18D17EEEQ34085116-BED2698E-8309-4CAB-86ED-7775AF8EBF9DQ34086794-89925499-784E-42D1-B95F-2143701210E1Q35577163-D56A51D2-A70F-451A-83A6-B816DC1E4236Q36181346-B32D92BD-8950-4B59-BCFA-E28C74F4EF43Q36944017-13644B78-C2EA-427E-9F29-3AB098433E72Q38018219-2B246612-28A4-4465-A7DB-2220FB6968D8Q38839950-47D6BA7B-41B5-452D-B800-05CD13573DD1Q43065203-78B6C634-9C41-4E45-93AB-44418CD86605Q43670035-0EE5B4EB-30CB-41CB-B8A4-72345BF45407Q44383883-A44BFC35-8B4D-425A-BF99-9E1E274AA4ADQ48381001-FFF85B26-EB38-4192-AB20-F7FB7563F727Q48573769-7D33EF6A-41A9-4B34-87FC-4C57653F1EAE
P2860
Pharmacotherapy of adolescent attention deficit hyperactivity disorder: challenges, choices and caveats
description
1998 nî lūn-bûn
@nan
1998 թուականին հրատարակուած գիտական յօդուած
@hyw
1998 թվականին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Pharmacotherapy of adolescent ...... hallenges, choices and caveats
@ast
Pharmacotherapy of adolescent ...... hallenges, choices and caveats
@en
Pharmacotherapy of adolescent ...... hallenges, choices and caveats
@nl
type
label
Pharmacotherapy of adolescent ...... hallenges, choices and caveats
@ast
Pharmacotherapy of adolescent ...... hallenges, choices and caveats
@en
Pharmacotherapy of adolescent ...... hallenges, choices and caveats
@nl
altLabel
Reviews : Pharmacotherapy of a ...... hallenges, choices and caveats
@en
Reviews : Pharmacotherapy of a ...... hallenges, choices and caveats
@nl
prefLabel
Pharmacotherapy of adolescent ...... hallenges, choices and caveats
@ast
Pharmacotherapy of adolescent ...... hallenges, choices and caveats
@en
Pharmacotherapy of adolescent ...... hallenges, choices and caveats
@nl
P2860
P921
P1476
Pharmacotherapy of adolescent ...... hallenges, choices and caveats
@en
Reviews : Pharmacotherapy of a ...... hallenges, choices and caveats
@en
P2093
E J Garland
E. Jane Garland
P2860
P356
10.1177/026988119801200410
P407
P577
1998-01-01T00:00:00Z
1998-07-01T00:00:00Z